Comprehensive pharmacogenomics characterization of temozolomide response in gliomas
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference102 articles.
1. Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis;Adel Fahmideh;Neuro Oncol.,2014
2. Pharmacokinetic study of temozolomide on a daily-for-5-days schedule in Japanese patients with relapsed malignant gliomas: first study in Asians;Aoki;Int. J. Clin. Oncol.,2007
3. Multiscale design of cell-type-specific pharmacokinetic/pharmacodynamic models for personalized medicine: application to temozolomide in brain tumors;Ballesta;CPT Pharmacometrics Syst. Pharmacol.,2014
4. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma;Bao;J. Cell. Biochem.,2019
5. Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer;Barault;Ann. Oncol.,2015
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Andrographolide sensitizes glioma to temozolomide by inhibiting DKK1 expression;British Journal of Cancer;2024-09-12
2. IDH1-mutant metabolite D-2-hydroxyglutarate inhibits proliferation and sensitizes glioma to temozolomide via down-regulating ITGB4/PI3K/AKT;Cell Death Discovery;2024-07-09
3. Hybrid Elmann-BiLSTM Based Brain Tumor Classification on Augmented Data with Combination of Variational Auto-Encoders and Generative Adversarial Network;Traitement du Signal;2024-04-30
4. Study of radiochemotherapy decision-making for young high-risk low-grade glioma patients using a macroscopic and microscopic combined radiomics model;European Radiology;2023-10-27
5. Emerging roles of m6A RNA modification in cancer therapeutic resistance;Experimental Hematology & Oncology;2023-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3